Differential expression of cysteine and aspartic proteases during progression of atherosclerosis in apolipoprotein E-deficient mice

American Journal of Pathology

Volumn 161, Issue 3, 2002, Pages 939-945

  Jormsjö, Sofia ^a   Wuttge, Dirk M ^a   Sirsjö, Allan ^a   Whatling, Carl ^a   Hamsten, Anders ^a   Stemme, Sten ^a   Eriksson, Per ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; ASPARTIC PROTEINASE; CATHEPSIN B; CATHEPSIN D; CATHEPSIN L; CYSTEINE PROTEINASE; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HYPERLIPOPROTEINEMIA TYPE 3; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

EID: 0036735233     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64254-X     Document Type: Article

References (26)

1. Arterial remodeling remocieling. Mechanisms and clinical implications
2. Properties and subcellular localization of elastase-like activities of arterial smooth muscle cells in culture
3. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation
4. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization
5. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques
6. Microscopic localization of active proteases by in situ zymography: Detection of matrix metalloproteinase activity in vascular tissue
7. Cathepsin S activity regulates antigen presentation and immunity
8. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells
9. Molecular regulation, membrane association and secretion of tumor cathepsin B
10. Increased activity of lysosomal enzymes in human atherosclerotic aortas
11. The specificity and elastinolytic activities of bovine cathepsins S and H
12. Functional expression of human cathepsin S in Saccharomyces cerevisiae. Purification and characterization of the recombinant enzyme
13. Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages
14. Emerging roles for cysteine proteases in human biology
15. Proteolytic degradation of low density lipoproteins by arterial smooth muscle cells: The role of individual cathepsins
16. Metabolism of native and naturally occurring multiple modified low density lipoprotein in smooth muscle cells of human aortic intima
17. Uptake of oxidized LDL by macrophages results in partial lysosomal enzyme inactivation and relocation
18. ApoEdeficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree
19. Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression
20. Enhanced expression of matrix metalloproteinase-3, -12, and -13 mRNAs in the aortas of apolipoprotein E-deficient mice with advanced atherosclerosis
21. In situ immunolocalization of lipoproteins in human arteriosclerotic tissue
22. Gene expression in atherosclerotic lesion of apoE deficient mice
23. Rat procathepsin B. Proteolytic processing to the mature form in vitro
24. Cathepsin D and cathepsin L activities in aortic aneurysm wall and parietal thrombus